Professur für Psychologische Methodenlehre
Standort/Location: München/Munich
Kontakt:
Charlotte-Fresenius-Hochschule
Infanteriestrasse 11a
80797 München
Email: stephan.goerigk@charlotte-fresenius-uni.de
T +49 (0)89 2000373-06
Eigene Projekte:
Kooperation:
Tendler, A., Goerigk, S., Zibman, S., Ouaknine, S., Harmelech, T., Pell, G. S., … & Roth, Y. (2023). Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis. Psychiatry Research, 324, 115179.
Bulubas, L., Goerigk, S., Gomes, J. S., Brem, A. K., Carvalho, J. B., Pinto, B. S., … & Valiengo, L. (2021). Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial. Schizophrenia research, 235, 44-51.
Goerigk, S. A., Padberg, F., Chekroud, A., Kambeitz, J., Bühner, M., & Brunoni, A. R. (2021). Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS. Brain Stimulation, 14(4), 906-912.
Goerigk, S. A., Padberg, F., Bühner, M., Sarubin, N., Kaster, T. S., Daskalakis, Z. J., … & Brunoni, A. R. (2021). Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trial. Neuropsychopharmacology, 46(4), 774-782.
Goerigk, S., Cretaz, E., Sampaio-Junior, B., Vieira, É. L. M., Gattaz, W., Klein, I., … & Brunoni, A. R. (2021). Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: results from a sham-controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 105, 110119.
Padberg, F., Bulubas, L., Mizutani-Tiebel, Y., Burkhardt, G., Kranz, G. S., Koutsouleris, N., … Goerigk, S. & Brunoni, A. R. (2021). The intervention, the patient and the illness–personalizing non-invasive brain stimulation in psychiatry. Experimental Neurology, 341, 113713.
Pittig, A., Heinig, I., Goerigk, S., Thiel, F., Hummel, K., Scholl, L., … & Wittchen, H. U. (2021). Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial. Depression and anxiety, 38(11), 1169-1181.
Kambeitz, J., Goerigk, S., Gattaz, W., Falkai, P., Bensenor, I. M., Lotufo, P. A., … & Brunoni, A. R. (2020). Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study. Journal of affective disorders, 265, 460-467.
Goerigk, S., Hilbert, S., Jobst, A., Falkai, P., Bühner, M., Stachl, C., … & Sarubin, N. (2020). Predicting instructed simulation and dissimulation when screening for depressive symptoms. European Archives of Psychiatry and Clinical Neuroscience, 270, 153-168.
Valiengo, L. D. C. L., Goerigk, S., Gordon, P. C., Padberg, F., Serpa, M. H., Koebe, S., … & Brunoni, A. R. (2020). Efficacy and safety of transcranial direct current stimulation for treating negative symptoms in schizophrenia: a randomized clinical trial. JAMA Psychiatry, 77(2), 121-129. Sampaio-Junior, B., Tortella, G., Borrione, L., Moffa, A. H., Machado-Vieira, R., Cretaz, E., Goerigk, S., … & Brunoni, A. R. (2018). Efficacy and safety of transcranial direct current stimulation as an add-on treatment for bipolar depression: a randomized clinical trial. JAMA Psychiatry, 75(2), 158-166.
Sara Vragolic M.Sc.
Standort/Location: München/Munich